AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (8.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Cancer stem cell specificity as new targets in breast tumor treatment

ZHIZHENG ZHANG#,1TAO LI#,2YUAN LI3XI WANG4HAO LIU5XINYU SHEN5ANN XU6TIANSONG XIA1( )BO XU7( )
Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
Department of Pathology, Jiangsu Provincial People’s Hospital, Nanjing, 210029, China
Department of Gynaecology and Obstetrics, No. 908th Hospital of Chinese PLA Joint Logistic Support Force, Nanchang, 330000, China
First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China
Department of Outpatient, Eastern Theater General Hospital, Nanjing, 210016, China
Zhejiang ZhongNuoMei Biotech Limited Company, Hangzhou, 310000, China
School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

#These authors contributed equally to this work

Show Author Information

Abstract

Background

Breast cancer is a prevalent malignant tumor affecting females, with treatment options including surgery, radiotherapy, chemotherapy, and endocrine therapy.

Methods

This review synthesizes existing literature on breast cancer stem cells and their applications in breast cancer treatment. PubMed, Web of Science, and other relevant databases were systematically searched using keywords such as “breast cancer stem cells,” “immunotherapy,” “gene therapy,” and “cell therapy.” Studies published in English were included, and their findings were analyzed to provide insights into the characteristics and therapeutic potential of breast cancer stem cells.

Results

Breast cancer stem cells exhibit unique properties that contribute to tumor initiation, progression, recurrence, and therapy resistance. Immunotherapy targeting breast cancer stem cells shows promise in overcoming these challenges, but issues such as lack of specificity and drug resistance need to be addressed.

Conclusions

Breast cancer stem cells represent promising targets for innovative therapeutic strategies aimed at improving treatment outcomes in breast cancer patients.

References

【1】
【1】
 
 
Oncology Research
Pages 811-819

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHANG Z, LI T, LI Y, et al. Cancer stem cell specificity as new targets in breast tumor treatment. Oncology Research, 2025, 33(4): 811-819. https://doi.org/10.32604/or.2024.050505

1079

Views

60

Downloads

4

Crossref

4

Web of Science

3

Scopus

Received: 08 February 2024
Accepted: 15 July 2024
Published: 30 April 2025
© The Author 2024.

This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.